Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
39901
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39902
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39903
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39904
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39905
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39906
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39907
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39908
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39909
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39910
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39911
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39912
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…<b>5k</b> represents a promising compound for further investigation as a potential treatment for breast cancer.…”
-
39913
MicroRNA-296-5p is differentially expressed in individuals with and without HIV-1 infection
Published 2021“…The decreased expression of miR-296-5p found in naïve patients with HIV infection suggests a regulatory activity of this miRNA on virus replication, making it a potential therapeutic agent against HIV. …”
-
39914
Klf4 has dual effects on the proliferation of epithelial cells in the cerebellum at E15.5.
Published 2015“…<p>a) Immunolabeling of BrdU in the cerebellum and b) counting of BrdU+ cells at E15.5. …”
-
39915
Image5_Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer.tif
Published 2023“…Two different molecular subtypes were identified according to the five CRGs. Then, we constructed a CRG_score applied to patients of any age, gender, and stage. …”
-
39916
Image_5_Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.jpg
Published 2021“…As part of the elongated structures in proximity to these membrane compartments, a pool of SNAP29 forms a complex with Syntaxin18, or with Syntaxin5, which we find is required to engage SEC22B-loaded vesicles. …”
-
39917
Image_5_Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.jpg
Published 2021“…As part of the elongated structures in proximity to these membrane compartments, a pool of SNAP29 forms a complex with Syntaxin18, or with Syntaxin5, which we find is required to engage SEC22B-loaded vesicles. …”
-
39918
-
39919
Image_5_Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab.TIFF
Published 2020“…<p>Membranous Nephropathy (MN) is an autoimmune disease associated with antibodies against podocyte proteins: M-type phospholipase A2 receptor (PLA2R1) or thrombospondin type-1 domain-containing 7A (THSD7A) in 70 and 3% of patients, respectively. …”
-
39920